Michael J. Sofia
Chief Scientific Officer at Arbutus Biopharma Corp (ABUS)
Michael J. Sofia has filed 5 insider reports with the SEC since February 2021, as chief Scientific Officer at Arbutus Biopharma Corp (ABUS). Michael J. Sofia made no open-market purchases or sales in the last 12 months. In the latest filing, on February 6, 2024, Michael J. Sofia sold 9,982 shares of Arbutus Biopharma Corp (ABUS) for $23.1K at an average of $2.31.
- Filings
- 5
- Companies
- 1
- Bought on market
- None
- Sold on market
- $1.04M
Companies where Michael J. Sofia is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| ABUS Arbutus Biopharma Corp | Chief Scientific Officer | 1,485,121 | $1.04M | $3.655 | Feb 6, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Feb 2, 2024-$23.1KABUSSofia Michael J. was granted 109,500 shares and sold $23,083 worth of shares (9,982 units at $2.31), increasing direct ownership by 7% to 1,485,121 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Feb 1, 2023ABUSSEC Form 4: Sofia Michael J. was granted 82,200 shares, increasing direct ownership by 6% to 1,385,603 units (withholding tax)Form 4Grant or award
- Jan 20, 2022ABUSSEC Form 4 filed by Sofia Michael J.Form 4Grant or award
- Dec 1, 2021-$1.02MABUSSEC Form 4: Sofia Michael J. sold $1,018,000 worth of shares (200,000 units at $5.09) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 1,303,403 unitsForm 4Open-market sale10b5-1 plan
- Feb 13, 2021ABUSSEC Form 4 filed by J. Michael SofiaForm 4Grant or award
Compare Michael J. Sofia with
- Michael J. Sofia vs Lindsay Androski1 shared
- Michael J. Sofia vs Tuan Nguyen1 shared
- Michael J. Sofia vs Roger Sawhney1 shared
- Michael J. Sofia vs Robert A Beardsley1 shared
- Michael J. Sofia vs Anuj Hasija1 shared
- Michael J. Sofia vs Matthew Gline1 shared
Other insiders at the same companies
- Lindsay AndroskiABUS
- Tuan NguyenABUS
- Roger SawhneyABUS
- Robert A BeardsleyABUS
- Anuj HasijaABUS
- Joseph E BishopABUS
- Matthew GlineABUS
- J. Christopher NaftzgerABUS
- Michael J. McElhaughABUS
- David C HastingsABUS
- Karen SimsABUS
Questions about Michael J. Sofia
- What is Michael J. Sofia's role at Arbutus Biopharma Corp?
- Michael J. Sofia reports to the SEC as chief Scientific Officer at Arbutus Biopharma Corp (ABUS), according to the latest filing on February 6, 2024.
- How many shares does Michael J. Sofia own?
- After the latest filing that states it, Michael J. Sofia directly owned 1,485,121 shares of Arbutus Biopharma Corp (ABUS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael J. Sofia bought or sold stock recently?
- The most recent open-market sale was on February 2, 2024: sold 9,982 shares of Arbutus Biopharma Corp (ABUS) for $23.1K at an average of $2.31.
- How do I get alerts when Michael J. Sofia files?
- Follow Michael J. Sofia on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael J. Sofia (SEC CIK 0001635324). Totals count each trade once, skipping amendments whose original is on file, from Feb 17, 2021 on. View on SEC EDGAR